AIM ImmunoTech Faces Delisting Concerns
Ticker: AIM · Form: 8-K · Filed: Jun 20, 2025 · CIK: 946644
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
AIM ImmunoTech might be delisted, filing 8-K on June 17th.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on June 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule on June 17, 2025. The filing also includes other events and financial statements and exhibits. The company's principal executive offices are located at 2117 SW Highway 484, Ocala, FL 34473.
Why It Matters
This filing indicates potential issues with AIM ImmunoTech's continued listing on an exchange, which could significantly impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's market presence and investor confidence.
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- June 20, 2025 (date) — Filing Date
- 2117 SW Highway 484, Ocala FL 34473 (location) — Principal executive offices
FAQ
What specific listing rule or standard did AIM ImmunoTech Inc. fail to satisfy?
The filing does not specify the exact rule or standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard was issued on June 17, 2025.
What is the significance of the filing date of June 20, 2025, versus the event date of June 17, 2025?
The filing date of June 20, 2025, is when the report was submitted to the SEC, while the event date of June 17, 2025, is the earliest date of the events being reported, specifically the notice of delisting.
What are the implications of a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' for AIM ImmunoTech Inc.?
This notice suggests that the company may be at risk of being removed from its stock exchange, which could lead to reduced liquidity, lower stock price, and difficulty in raising capital.
Does the filing provide any details on the 'Other Events' or 'Financial Statements and Exhibits' mentioned?
The provided text is a header and does not contain the detailed content of the 'Other Events' or 'Financial Statements and Exhibits' sections; it only indicates their inclusion in the filing.
What was AIM ImmunoTech Inc.'s former name and when did the name change occur?
AIM ImmunoTech Inc.'s former name was HEMISPHERX BIOPHARMA INC, and the date of the name change was June 14, 1995.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding AIM ImmunoTech Inc. (AIM).